ORBIMED ADVISORS LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1055951 New York, NY

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$11,357,808

-$36,158,240 QoQ

Shares Held

14,700

-67.5% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	EWTX	Edgewise Therapeutics, Inc.	15,518,492	$630,516,329
2	ELVN	Enliven Therapeutics, Inc.	6,776,632	$343,914,074
3	MBX	MBX Biosciences, Inc.	3,428,736	$189,266,227
4	GPCR	Structure Therapeutics Inc.	2,209,400	$118,578,498
5	SION	Sionna Therapeutics, Inc.	2,555,877	$112,433,029
6	CRVS	Corvus Pharmaceuticals, Inc.	7,165,006	$107,045,189
7	AVBP	ArriVent BioPharma, Inc.	3,027,328	$105,169,374
8	ARGX	Argenx SE	92,880	$86,171,277

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,357,808	14,700	-67.5%	Shares	Sole	2026-05-15
2024-09-30	$47,516,048	45,200	+98.2%	Shares	Defined	2024-11-14
2024-06-30	$23,963,484	22,800	0.0%	Shares	Sole	2024-08-14
2024-03-31	$21,944,772	22,800	+68.9%	Shares	Sole	2024-05-15
2023-12-31	$11,856,915	13,500	0.0%	Shares	Sole	2024-02-14
2023-09-30	$11,109,960	13,500	0.0%	Shares	Sole	2023-11-14
2023-06-30	$9,700,290	13,500	-43.8%	Shares	Sole	2023-08-14
2023-03-31	$19,720,080	24,000	+8.1%	Shares	Sole	2023-05-15
2022-06-30	$13,123,086	22,200	+63.7%	Shares	Sole	2022-08-15
2021-09-30	$8,206,240	13,560	-56.1%	Shares	Defined	2021-11-15
2020-06-30	$19,270,785	30,900	+79.7%	Shares	Sole	2020-08-14
2020-03-31	$8,398,588	17,200	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.